Adiponectin as a growth inhibitor in prostate cancer cells
- 27 December 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 340 (4), 1158-1166
- https://doi.org/10.1016/j.bbrc.2005.12.103
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3Biochemical and Biophysical Research Communications, 2005
- Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone‐refractory prostate carcinomaCancer, 2004
- Obesity and the risk of prostate cancerThe Prostate, 2004
- Prostate Cancer Cell-Adipocyte InteractionJournal of Biological Chemistry, 2003
- Association of Hypoadiponectinemia With Impaired VasoreactivityHypertension, 2003
- Oligomerization State-dependent Activation of NF-κB Signaling Pathway by Adipocyte Complement-related Protein of 30 kDa (Acrp30)Journal of Biological Chemistry, 2002
- Interleukin-6- and Cyclic AMP-Mediated Signaling Potentiates Neuroendocrine Differentiation of LNCaP Prostate Tumor CellsMolecular and Cellular Biology, 2001
- Leptin and prostate cancerThe Prostate, 2001
- AdipoQ Is a Novel Adipose-specific Gene Dysregulated in ObesityJournal of Biological Chemistry, 1996
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996